Keros Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need.

CEO

Jasbir S. Seehra

CEOJasbir S. Seehra

Employees

169

Employees169

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2015

Founded2015

Employees

169

Employees169

KROS Key Statistics

Market cap

573.08M

Market cap573.08M

Price-Earnings ratio

-76.46

Price-Earnings ratio-76.46

Dividend yield

—

Dividend yield—

Average volume

852.88K

Average volume852.88K

High today

$14.44

High today$14.44

Low today

$13.95

Low today$13.95

Open price

$14.05

Open price$14.05

Volume

578.99K

Volume578.99K

52 Week high

$72.37

52 Week high$72.37

52 Week low

$9.12

52 Week low$9.12

Analyst ratings

67%

of 12 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own KROS. This list is generated using Robinhood data, and it’s not a recommendation.